Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 239
Filter
1.
Br J Cancer ; 101(9): 1580-4, 2009 Nov 03.
Article in English | MEDLINE | ID: mdl-19809432

ABSTRACT

BACKGROUND: Diagnosis of oral cancer is conventionally carried out using white light endoscopy and histopathology of biopsy samples. However, oral tumours are mostly superficial and the lesion and its margins can be difficult to visualise under white light. We present clinical data on fluorescence diagnostic imaging of oral lesions using hypericin, a plant-based photosensitiser. METHODS: Fluorescence images of lesions and normal tissue were captured using an endoscope after hypericin administration. The images were analysed to extract their colour parameters, which, along with the red-to-blue intensity ratios, were analysed and used to discriminate between tissue types. The results were correlated with those from histopathology. RESULTS: The red-to-blue intensity ratio increased from normal to hyperplastic to cancerous tissue and was a good parameter to discriminate between these tissue types, with sensitivity and specificity levels of 90% and above. CONCLUSION: Our results show that hypericin fluorescence imaging has the potential to be used for the clinical diagnosis of oral cancer. Further study to enhance the clinical potential of this technique includes the development of a real-time image processing and analysis system interfaced to the endoscope to enable same-day cancer diagnosis and demarcation of lesion margins in a clinical setting.


Subject(s)
Diagnostic Imaging/methods , Mouth Neoplasms/diagnosis , Perylene/analogs & derivatives , Adult , Aged , Aged, 80 and over , Anthracenes , Carcinoma, Squamous Cell/diagnosis , Endoscopy , Female , Fluorescence , Humans , Hyperplasia , Male , Middle Aged , Mouth Mucosa/pathology
2.
Neuroendocrinology ; 74(5): 309-24, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11694763

ABSTRACT

Both the estrogen receptor (ER) and thyroid hormone receptor (TR) are members of the nuclear receptor superfamily. Two isoforms of the ER, alpha and beta, exist. The TRalpha and beta isoforms are products of two distinct genes that are further differentially spliced to give TRalpha1 and alpha2, TRbeta1 and beta2. The TRs have been shown to interfere with ER-mediated transcription from both the consensus estrogen response element (ERE) and the rat preproenkephalin (PPE) promoter, possibly by competing with ER binding to the ERE or by squelching coactivators essential for ER-mediated transcription. The rat oxytocin receptor (OTR) gene is thought to be involved in several facets of reproductive and affiliative behaviors. 17beta-Estradiol-bound ERs upregulate the OTR gene in the ventromedial hypothalamus, a region critical for the induction of lordosis behavior in several species. We investigated the effects of the ligand-binding TR isoforms on the ER-mediated transcription from a physiological promoter of a behaviorally relevant gene such as the OTR. Only ERalpha could induce the OTR gene in two cell lines tested, the CV-1 and the SK-N-BE2C neuroblastoma cell lines. ERbeta was incapable of inducing the gene in either cell line. ERalpha is therefore not equivalent to ERbeta on this physiological promoter. Indeed, in the neural cell line, ERbeta can inhibit ERalpha-mediated induction from the OTR promoter. While the TRalpha1 isoform inhibited ERalpha-mediated induction in the neural cell line, the TRbeta1 isoform stimulated induction, thus demonstrating isoform specificity in the interaction. The use of a DNA-binding mutant, the TR P box mutant, showed that inhibition of ERalpha-mediated induction of the rat OTR gene promoter by the TRalpha1 isoform does not require DNA-binding ability. SRC-1 overexpression relieved TRalpha1-mediated inhibition in both cell lines, suggesting that squelching for coactivators is an important molecular mechanism in TRalpha-mediated inhibition. Such interactions between TR and ER isoforms on the rat OTR promoter provide a mechanism to achieve neuroendocrine integration.


Subject(s)
Promoter Regions, Genetic/physiology , Receptors, Estrogen/physiology , Receptors, Oxytocin/genetics , Receptors, Thyroid Hormone/physiology , Transcription, Genetic/physiology , Animals , Cell Line , DNA-Binding Proteins/physiology , Estradiol/pharmacology , Estrogen Receptor alpha , Gene Expression Regulation/physiology , Mutation/physiology , Promoter Regions, Genetic/drug effects , Protein Isoforms/physiology , Rats , Receptors, Cytoplasmic and Nuclear/physiology , Receptors, Thyroid Hormone/genetics , Response Elements/physiology
3.
Brain Res Mol Brain Res ; 95(1-2): 9-17, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11687272

ABSTRACT

Crosstalk between nuclear receptors is important for conversion of external and internal stimuli to a physiologically meaningful response by cells. Previous studies from this laboratory have demonstrated crosstalk between the estrogen (ER) and thyroid hormone receptors (TR) on two estrogen responsive physiological promoters, the preproenkephalin and oxytocin receptor gene promoter. Since ERalpha and ERbeta are isoforms possessing overlapping and distinct transactivation properties, we hypothesized that the interaction of ERalpha and beta with the various TR isoforms would not be equivalent. To explore this hypothesis, the consensus estrogen response element (ERE) derived from the Xenopus vitellogenin gene is used to investigate the differences in interaction between ERalpha and beta isoforms and the different TR isoforms in fibroblast cells. Both the ER isoforms transactivate from the consensus ERE, though ERalpha transactivates to a greater extent than ERbeta. Although neither of the TRbeta isoforms have an effect on ERalpha transactivation from the consensus ERE, the liganded TRalpha1 inhibits the ERalpha transactivation from the consensus ERE. In contrast, the liganded TRalpha1 facilitates ERbeta-mediated transactivation. The crosstalk between the TRbeta isoforms with the ERalpha isoform, on the consensus ERE, is different from that with the ERbeta isoform. The use of a TRalpha1 mutant, which is unable to bind DNA, abolishes the ability of the TRalpha1 isoform to interact with either of the ER isoforms. These differences in nuclear receptor crosstalk reveal an important functional difference between isoforms, which provides a novel mechanism for neuroendocrine integration.


Subject(s)
Receptor Cross-Talk , Receptors, Estrogen/physiology , Receptors, Thyroid Hormone/physiology , Animals , Cell Line , Chlorocebus aethiops , Consensus Sequence , Estrogen Receptor alpha , Estrogen Receptor beta , Ligands , Protein Isoforms/physiology , Response Elements , Transcription, Genetic , Vitellogenins/genetics
4.
J Neuroendocrinol ; 13(9): 779-90, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11578528

ABSTRACT

Nuclear receptors are ligand-activated transcription factors, which have the potential to integrate internal metabolic events in an organism, with consequences for control of behaviour. Previous studies from this laboratory have shown that thyroid hormone receptor (TR) isoforms can inhibit oestrogen receptor (ER)alpha-mediated induction of preproenkephalin (PPE) gene expression in the hypothalamus. Also, thyroid hormone administration inhibits lordosis, a behaviour facilitated by PPE expression. We have examined the effect of multiple ligand-binding TR isoforms on the ER-mediated induction of the PPE gene in transient transfection assays in CV-1 cells. On a natural PPE gene promoter fragment containing two putative oestrogen response elements (EREs), both ER alpha and beta isoforms mediate a four to five-fold induction by oestrogen. Cotransfection of TR alpha 1 along with ER alpha inhibited the ER alpha transactivation of PPE by approximately 50%. However, cotransfection with either TR beta 1 or TR beta 2 expression plasmids produced no effect on the ER alpha or ER beta mediated induction of PPE. Therefore, under these experimental conditions, interactions with a single ER isoform are specific to an individual TR isoform. Transfection with a TR alpha 1 DNA-binding mutant could also inhibit ER alpha transactivation, suggesting that competition for binding on the ERE may not be the exclusive mechanism for inhibition. Data with the coactivator, SRC-1, suggested that coactivator squelching may participate in the inhibition. In dramatic contrast, when ER beta is cotransfected, TR alpha 1 stimulated ER beta-mediated transactivation of PPE by approximately eight-fold over control levels. This is the first study revealing specific interactions among nuclear receptor isoforms on a neuroendocrine promoter. These data also suggest that the combinatorics of ER and TR isoforms allow multiple forms of flexible gene regulations in the service of neuroendocrine integration.


Subject(s)
Enkephalins/genetics , Gene Expression Regulation/physiology , Protein Precursors/genetics , Receptor Cross-Talk/physiology , Receptors, Estrogen/physiology , Receptors, Thyroid Hormone/physiology , Animals , Cell Line , Protein Isoforms/physiology , Rats
5.
Thyroid ; 11(9): 811, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11575848
6.
J Comp Neurol ; 437(3): 286-95, 2001 Aug 27.
Article in English | MEDLINE | ID: mdl-11494256

ABSTRACT

Estrogen receptors (ER) and thyroid hormone receptors (TR) are members of the nuclear receptor family of transcription factors that induce or repress the expression of target genes. Previous behavioral studies in female rodents have demonstrated that thyroid hormones can antagonize the effects of estrogen in the central nervous system (CNS), particularly by attenuating estrogen's ability to facilitate reproductive behaviors. Additional molecular studies have suggested a mechanism for this antagonism by showing that ligand-activated ER alpha and TRs have the potential to interact in their transcriptional controls. Although the expression patterns of ER alpha and TRs in the rodent brain appear to overlap in behaviorally relevant areas, it remained to be determined whether these two classes of proteins coexist in vivo at the level of single neurons. To address this possibility, we employed a highly sensitive double-label in situ hybridization technique using digoxigenin and (35)S-labeled cRNA probes to analyze, in detail, the expression of ER alpha mRNA with TR alpha 1 and TR alpha 2 mRNAs in the same neurons of the ovariectomized (OVX) adult mouse brain. Our results demonstrate that a large majority of the ER alpha-positive neurons also expresses TR alpha 1 and TR alpha 2 mRNAs. Quantitative examination of the cellular expression in the ventromedial and arcuate nuclei of the hypothalamus (VMH and Arc) showed that 81.5% and 80.5% of the neurons endowed with ER alpha mRNA also contain TR alpha 1 and TR alpha 2 mRNAs, respectively. In the amygdala, more than 60.5% and 67% of ER alpha-positive cells also contain TR alpha 1 and TR alpha 2 mRNAs, respectively. These findings provide the first anatomical evidence that ER and TR can be found in the same neurons, including hypothalamic neurons. This coexpression of ER alpha and TR provides the cellular basis for a new level of neuronal integration in a brain region where estrogens control female reproductive behaviors.


Subject(s)
Gene Expression Regulation/physiology , Hypothalamus/metabolism , Neurons/metabolism , RNA, Messenger/metabolism , Receptors, Estrogen/genetics , Receptors, Thyroid Hormone/genetics , Amygdala/metabolism , Animals , Arcuate Nucleus of Hypothalamus/cytology , Arcuate Nucleus of Hypothalamus/metabolism , Estrogen Receptor alpha , Female , Hypothalamus/cytology , In Situ Hybridization , Mice , Neurons/cytology , Protein Isoforms/genetics , Ventromedial Hypothalamic Nucleus/cytology , Ventromedial Hypothalamic Nucleus/metabolism
7.
J Biol Chem ; 276(36): 33375-83, 2001 Sep 07.
Article in English | MEDLINE | ID: mdl-11443112

ABSTRACT

We previously cloned and characterized thyroid hormone receptor-binding protein (TRBP) as an LXXLL-containing general coactivator that associates with coactivator complexes through its C terminus. To identify protein cofactors for TRBP action, a Sos-Ras yeast two-hybrid cDNA library was screened using TRBP C terminus as bait. A novel coactivator was isolated, coactivator activator (CoAA), that specifically associates with TRBP. Human CoAA is composed of 669 amino acids with a TRBP-interacting domain and two highly conserved RNA recognition motifs (RRM) commonly found in ribonucleoproteins. A splice variant lacking the entire TRBP-interacting domain was also isolated as a coactivator modulator (CoAM), a 156-amino acid protein containing only the RRM region. Human CoAA and CoAM mRNAs are encoded by a single gene located on chromosome 11q13; alternative splicing in exon 2 of CoAA yields CoAM. CoAA interacts with both TRBP and p300 in vitro. In addition, CoAA potently coactivates transcription mediated by multiple hormone-response elements and acts synergistically with TRBP and CREB-binding protein (CBP). Furthermore, CoAA is associated with the DNA-dependent protein kinase-poly(ADP-ribose) polymerase complex. Strikingly, CoAM, which lacks a TRBP-interacting domain, strongly represses both TRBP and CBP action suggesting that CoAM may modulate endogenous CoAA function. These data suggest that CoAA may serve as a mediator of coactivators such as TRBP in gene activation.


Subject(s)
Alternative Splicing , Carrier Proteins/chemistry , Carrier Proteins/genetics , Intracellular Signaling Peptides and Proteins , Amino Acid Sequence , Amino Acids/chemistry , Animals , Base Sequence , Cell Nucleus/metabolism , Cells, Cultured , Chromosomes, Human, Pair 11 , Cloning, Molecular , DNA, Complementary/metabolism , E1A-Associated p300 Protein , Enzyme Activation , Exons , Gene Library , Glutathione Transferase/metabolism , Humans , Introns , Mice , Models, Genetic , Molecular Sequence Data , Nuclear Proteins/metabolism , Plasmids/metabolism , Poly(ADP-ribose) Polymerases/metabolism , Protein Binding , Protein Structure, Tertiary , RNA, Messenger/metabolism , RNA-Binding Proteins/metabolism , Rats , Recombinant Fusion Proteins/metabolism , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid , Temperature , Tissue Distribution , Trans-Activators/metabolism , Transcription, Genetic , Transfection , Two-Hybrid System Techniques
8.
Brain Res Mol Brain Res ; 91(1-2): 23-33, 2001 Jul 13.
Article in English | MEDLINE | ID: mdl-11457489

ABSTRACT

Estrogen receptors (ER) and thyroid hormone receptors (TR) are ligand-dependent nuclear transcription factors. Estrogen-induced preproenkephalin (PPE) gene expression in the hypothalamus is directly related to estrogen-induced lordosis behavior in the rat. In the present study, we showed that the PPE mRNA level in the ventromedial hypothalamus of female rats was significantly decreased by ovariectomy. This decrease was reversed by estrogen replacement in a dose- and time-dependent manner. Using transient transfection and electrophoretic mobility shift assays (EMSA), functional estrogen response elements (ERE) were identified between -437 and -145 base pairs (bp) of the rat PPE gene promoter region. Two ERE-like elements are present between -405 and -364 of the rat PPE gene promoter, which bind ERalpha as demonstrated by EMSA. Estrogen produced a dose-dependent increase in CAT activity in cotransfection assays with ERalpha expression vector and a 437PPE-CAT reporter construct containing 437 bp of the rat PPE gene promoter and the CAT reporter gene. This estrogen-induced PPE promoter activity was inhibited by liganded-TR in transient cotransfection assays. Analysis of DNA-protein interactions by EMSA revealed that both ERalpha and TR (alpha1 and beta1) could bind to the EREs in the rat PPE gene promoter. Furthermore, estrogen induction of PPE mRNA in the ventromedial hypothalamus of the ovariectomized female rat was significantly attenuated by concomitant administration of triiodothyronine. These results suggest that estrogen regulation of the hypothalamic PPE gene expression is mediated through an estrogen-receptor complex directly interacting with the functional EREs in its promoter region; and that this estrogen effect can be modified by thyroid hormones.


Subject(s)
Enkephalins/genetics , Estrogens/pharmacology , Protein Precursors/genetics , Thyroid Hormones/metabolism , Ventromedial Hypothalamic Nucleus/physiology , Animals , Cells, Cultured , Estrogens/metabolism , Female , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Ovariectomy , Promoter Regions, Genetic/physiology , Rats , Rats, Sprague-Dawley , Transfection
9.
Thyroid ; 11(3): 205-10, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11327610

ABSTRACT

Thyroid hormone (TH) plays an important role in brain development. The rodent cerebellum has been an excellent model for the study of the molecular mechanisms of TH action in brain. However, most studies have utilized the rat rather than the mouse. Considering the usefulness of mice with regard to diverse genetic models, the study of TH effect on mouse cerebellar development is needed. Thus, we examined the effect of perinatal hypothyroidism on the expression of neurotrophin-3 (NT-3) and brain-derived neurotrophic factor (BDNF) genes, which play critical roles in cerebellar development. Newborn mice were rendered hypothyroid by administering methimazole and perchlorate in drinking water to their mothers. The growth of hypothyroid mice was retarded, which was reversed by daily thyroxine administration. NT-3 and BDNF gene expression was depressed in the perinatal hypothyroid cerebellum. Furthermore, the expression of retinoid-receptor-related orphan nuclear hormone receptor-alpha (RORalpha), an orphan nuclear receptor that plays critical roles in Purkinje cell development, was also decreased. Morphologically, disappearance of the external granule cell layer was retarded and arborization of Purkinje cell dendrite was decreased, events that were also observed in hypothyroid rats. These results indicate that the mouse cerebellum is comparable to the rat cerebellum as a model for the examination of the molecular mechanisms of TH action in brain development.


Subject(s)
Cerebellum/growth & development , Gene Expression , Hypothyroidism/metabolism , Neurotrophin 3/genetics , Aging , Animals , Autoradiography , Body Weight , Brain-Derived Neurotrophic Factor/genetics , Female , Hypothyroidism/drug therapy , Male , Mice , Mice, Inbred C57BL , Nuclear Receptor Subfamily 1, Group F, Member 1 , RNA, Messenger/analysis , Receptors, Cytoplasmic and Nuclear/genetics , Thyroxine/therapeutic use , Trans-Activators/genetics
10.
Eur J Endocrinol ; 144(2): 139-44, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11182750

ABSTRACT

OBJECTIVE: The acute decrease in iodide organification in the thyroid in response to excess iodide is termed the acute Wolff-Chaikoff effect and normal organification resumes in spite of continued high plasma iodide concentrations (escape from the acute Wolff-Chaikoff effect). We have recently reported that large doses of iodide given to rats chronically decrease the sodium/iodide symporter (NIS) mRNA and protein, suggesting that escape is due to a decrease in NIS and subsequent iodide transport. We have now studied the effect of excess iodide on NIS in FRTL-5 cells to further explore the mechanisms whereby excess iodide decreases NIS. DESIGN: FRTL-5 cells were employed and were incubated in the presence or absence of various concentrations of iodide. NIS mRNA and protein and the turnover of NIS were assessed. METHODS: NIS mRNA was measured by Northern analysis, NIS protein by Western analysis and NIS turnover by pulse-chase labeling experiments. RESULTS: Iodide (10(-) mol/l) had no effect on NIS mRNA in FRTL-5 cells at 24 and 48 h compared with cells cultured in the absence of iodide. However, excess iodide decreased NIS protein by 50% of control values at 24 h and by 70% at 48 h. This effect of iodide was dose dependent. Pulse-chase experiments demonstrated that there was no effect of iodide on new NIS protein synthesis and that the turnover of NIS protein in the presence of iodide was 27% faster than in the absence of added iodide. CONCLUSIONS: Excess iodide does not decrease NIS mRNA in FRTL-5 cells but does decrease NIS protein, suggesting that in this in vitro thyroid cell model iodide modulates NIS, at least in part, at a post-transcriptional level. This iodide-induced decrease in NIS protein appears to be due, at least partially, to an increase in NIS protein turnover.


Subject(s)
Carrier Proteins/antagonists & inhibitors , Membrane Proteins/antagonists & inhibitors , Sodium Iodide/pharmacology , Symporters , Thyroid Gland/metabolism , Thyrotropin/physiology , Animals , Carrier Proteins/genetics , Cell Line , Membrane Proteins/genetics , RNA, Messenger/metabolism , Rats , Thyroid Gland/cytology , Thyrotropin/pharmacology
11.
Mol Cell Endocrinol ; 172(1-2): 13-20, 2001 Feb 14.
Article in English | MEDLINE | ID: mdl-11165035

ABSTRACT

Recent evidence indicates that corepressor protein with histone deacetylase (HDAC) activity mediates thyroid hormone receptor (TR) transcriptional repression. In order to examine the physiological relevance of HDAC in ligand-independent TR-mediated repression, we studied the effect of trichostatin A (TSA), a specific HDAC inhibitor, in transient transfection studies with natural reporters, and assessed the expression of TR-regulated endogenous genes. Luciferase-coupled DR4-, F2-, PAL- or GH-TREs and TRbeta1 expression vectors were cotransfected in CV-1 and GH(3) cells. We did not observe any effect of TSA on TR-induced basal repression in CV-1 cells. Instead, TSA was able to induce an increase in transcription without T(3) on all TREs tested in GH(3) cells. This increase was >7-fold on F2-, >4-fold on DR4-, and 3-fold on GH-TREs. The cotransfection of a TRbeta1 mutant that exhibits decreased affinity with N-CoR (AHT) reduced the TSA effect in GH(3) cells, demonstrating a primary role for TR/N-CoR/Sin3/HDAC complex. Next, we examined the effects of TSA on endogenous GH mRNA production in GH(3) cells by Northern blot analysis. We observed an increase of 50-70% of GH mRNA in cells treated with TSA in hypothyroid medium, and an increase of GH mRNA in T(3)-treated cells after TSA treatment. Our results show that TSA can increase the expression of endogenous genes that are susceptible to TR regulation. These results support an active role of HDAC in transcriptional repression by ligand-independent TR.


Subject(s)
Histone Deacetylases/genetics , Receptors, Thyroid Hormone/genetics , Repressor Proteins/pharmacology , Animals , Cell Line , Enzyme Inhibitors/pharmacology , Gene Expression Regulation/drug effects , Genes, Reporter/drug effects , Growth Hormone/genetics , Histone Deacetylase Inhibitors , Histone Deacetylases/physiology , Hydroxamic Acids/pharmacology , Kidney/cytology , Organ Specificity , Pituitary Gland/cytology , Rats , Response Elements/genetics , Transcription, Genetic/drug effects , Transfection
12.
Nature ; 407(6803): 538-41, 2000 Sep 28.
Article in English | MEDLINE | ID: mdl-11029009

ABSTRACT

Oestrogen produces diverse biological effects through binding to the oestrogen receptor (ER). The ER is a steroid hormone nuclear receptor, which, when bound to oestrogen, modulates the transcriptional activity of target genes. Controversy exists, however, concerning whether ER has a role outside the nucleus, particularly in mediating the cardiovascular protective effects of oestrogen. Here we show that the ER isoform, ER alpha, binds in a ligand-dependent manner to the p85alpha regulatory subunit of phosphatidylinositol-3-OH kinase (PI(3)K). Stimulation with oestrogen increases ER alpha-associated PI(3)K activity, leading to the activation of protein kinase B/Akt and endothelial nitric oxide synthase (eNOS). Recruitment and activation of PI(3)K by ligand-bound ER alpha are independent of gene transcription, do not involve phosphotyrosine adapter molecules or src-homology domains of p85alpha, and extend to other steroid hormone receptors. Mice treated with oestrogen show increased eNOS activity and decreased vascular leukocyte accumulation after ischaemia and reperfusion injury. This vascular protective effect of oestrogen was abolished in the presence of PI(3)K or eNOS inhibitors. Our findings define a physiologically important non-nuclear oestrogen-signalling pathway involving the direct interaction of ER alpha with PI(3)K.


Subject(s)
Phosphatidylinositol 3-Kinases/metabolism , Receptors, Estrogen/metabolism , Animals , Binding Sites , Cattle , Cells, Cultured , Endothelium, Vascular/metabolism , Estrogens/metabolism , Humans , Male , Mice , Mice, Inbred C57BL , Nitric Oxide/metabolism , Protein Binding , Protein Isoforms/metabolism , Recombinant Fusion Proteins/metabolism , Signal Transduction
13.
Endocrinology ; 141(6): 2275-8, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10830318

ABSTRACT

Thyroid hormone receptor (TR), a ligand-mediated transcription factor, binds to a DNA sequence known as a thyroid-hormone response element (TRE) to activate or repress transcription of target genes. Recently, studies have shown that Ca2+/calmodulin-dependent protein kinases (CaMKs) may be involved in regulating gene transcription via phosphorylation of specific transcription factors, including RORalpha, a retinoic acid-related orphan nuclear hormone receptor. In this light, we examined the effect of CaMK type IV (CaMKIV) and RORalpha, which also shown to influence thyroid hormone action, on TR-mediated transcription using a transient transfection assay. Expression vectors containing TR, vitamin D receptor (VDR), and estrogen receptor (ER) were cotransfected in CV-1 cells with RORalpha and/or constitutively active CaMKIV and thymidine kinase promotor-luciferase reporter vector containing their cognate response elements. When CaMKIV or RORalpha was co-transfected with TR, the T3-induced transcription was significantly augmented compared to that induced by TR alone. When both were co-transfected with TR, T3-induced transcription was augmented additively. In contrast, the augmentation by CaMKIV or ROR on ligand-induced transcription was not detected with VDR and ER. Hence, these results indicate that the augmentation mediated by CaMKIV and RORalpha is specific for TR-mediated transcription on TRE. Our results suggest that CaMKIV, as well as RORalpha, play important roles in TR-mediated transcription on TREs.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Isoenzymes/metabolism , Receptors, Thyroid Hormone/physiology , Transcription, Genetic , Animals , Humans , Luciferases/genetics , Promoter Regions, Genetic , Rats , Receptors, Calcitriol/genetics , Receptors, Calcitriol/physiology , Receptors, Estrogen/genetics , Receptors, Estrogen/physiology , Receptors, Retinoic Acid/genetics , Receptors, Retinoic Acid/physiology , Receptors, Thyroid Hormone/genetics , Recombinant Fusion Proteins , Thymidine Kinase/genetics , Transcription, Genetic/drug effects , Transfection , Triiodothyronine/pharmacology
14.
Endocrinology ; 141(5): 1693-8, 2000 May.
Article in English | MEDLINE | ID: mdl-10803578

ABSTRACT

Thyroid hormone (TH) plays an important role in the postnatal development of the rodent cerebellum, particularly within the first 2 weeks of postnatal life. This action is exerted through the regulation of specific genes during development and is mediated by coactivator and corepressor proteins that determine transcriptional repression or activation, respectively. Thus, we hypothesized that the effect of TH on rodent cerebellar development could be influenced by the relative amounts of coactivator and corepressor proteins in vivo. These ratios might be modulated in an age-specific manner and/or by hormones to generate the "critical period" of TH action. To examine this hypothesis, we cloned rat complementary DNA fragments corresponding to coactivators (SRC1, TIF2 and TRAM1) and corepressors (N-CoR and SMRT), and studied the ontogenic changes in their corresponding messenger RNAs in rat cerebellum of normal and hypothyroid rats during postnatal development, using a RNase protection assay. We found an increased expression of SRC1 and TIF2, as well as of N-CoR, during rat cerebellar development but no change in the expression of SMRT and TRAM1 genes. However, thyroid hormone status did not affect the expression of coactivator and corepressor genes in the cerebellum. These results indicate that coactivator and corepressor messenger RNAs exhibit differential expression through cerebellar development but are not regulated by TH during this period.


Subject(s)
Cerebellum/growth & development , DNA-Binding Proteins/genetics , Gene Expression Regulation, Developmental , Nuclear Proteins/genetics , Repressor Proteins/genetics , Thyroid Hormones/physiology , Transcription Factors/genetics , Aging , Animals , Base Sequence , DNA-Binding Proteins/biosynthesis , Histone Acetyltransferases , Humans , Hypothyroidism/genetics , Hypothyroidism/metabolism , Mice , Molecular Sequence Data , Nuclear Proteins/biosynthesis , Nuclear Receptor Co-Repressor 1 , Nuclear Receptor Co-Repressor 2 , Nuclear Receptor Coactivator 1 , Nuclear Receptor Coactivator 2 , Nuclear Receptor Coactivator 3 , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Repressor Proteins/biosynthesis , Thyroxine/pharmacology , Transcription Factors/biosynthesis
15.
Proc Natl Acad Sci U S A ; 97(11): 6212-7, 2000 May 23.
Article in English | MEDLINE | ID: mdl-10823961

ABSTRACT

Nuclear hormone receptors activate gene transcription through ligand-dependent association with coactivators. Specific LXXLL sequence motifs present in these cofactors are sufficient to mediate these ligand-induced interactions. A thyroid hormone receptor (TR)-binding protein (TRBP) was cloned by a Sos-Ras yeast two-hybrid system using TRbeta1-ligand binding domain as bait. TRBP contains 2063 amino acid residues, associates with TR through a LXXLL motif, and is ubiquitously expressed in a variety of tissues and cells. TRBP strongly transactivates through TRbeta1 and estrogen receptor in a dose-related and ligand-dependent manner, and also exhibits coactivation through AP-1, CRE, and NFkappaB-response elements, similar to the general coactivator CBP/p300. The C terminus of TRBP binds to CBP/p300 and DRIP130, a component of the DRIP/TRAP/ARC complex, which suggests that TRBP may activate transcription by means of such interactions. Further, the association of TRBP with the DNA-dependent protein kinase (DNA-PK) complex and DNA-independent phosphorylation of TRBP C terminus by DNA-PK point to a potential connection between transcriptional control and chromatin architecture regulation.


Subject(s)
DNA-Binding Proteins , Intracellular Signaling Peptides and Proteins , Trans-Activators/isolation & purification , Transcription, Genetic , Amino Acid Motifs , Amino Acid Sequence , Animals , CREB-Binding Protein , Cell Line , Cell Nucleus/metabolism , Chlorocebus aethiops , DNA-Activated Protein Kinase , Genes, Reporter , HeLa Cells , Humans , Mediator Complex , Molecular Sequence Data , Nuclear Proteins/metabolism , Nuclear Receptor Coactivators , Protein Serine-Threonine Kinases/metabolism , Receptors, Estrogen/physiology , Receptors, Thyroid Hormone/physiology , Recombinant Fusion Proteins/metabolism , Trans-Activators/chemistry , Trans-Activators/genetics , Trans-Activators/metabolism , Trans-Activators/physiology , Transcription Factors/metabolism , Transfection , Two-Hybrid System Techniques
16.
Endocrinology ; 141(3): 1281-4, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10698207

ABSTRACT

Vitamin D receptor (VDR) is a ligand-dependent transcription factor that regulates target gene expression. Although VDR forms stable heterodimer complex with retinoid X receptors (RXRs) on vitamin D-response elements (VDREs), it is still not clear whether VDR/RXR heterodimers are the only VDR complexes responsible for vitamin D-mediated gene transcription. In this report, we analyzed the effect of nuclear receptor coactivators (SRC-1 and TRAM-1) on VDR homodimer and VDR/RXR heterodimer formation by electrophoretic mobility shift assay. We found that VDR forms stable homodimers after interaction with the coactivators on a VDRE (DR+3). Of particular note, DR+4 and DR+5 hormone-response elements (HREs) may also support such interactions. Cotransfection experiments revealed further that the coactivators enhance ligand-induced VDR transcription on these elements. Our studies suggest the important role of VDR homodimers, in addition to VDR/RXR heterodimers, in vitamin D-induced transactivation. Thus, specific coactivator-VDR interactions on HREs may determine target gene transactivation.


Subject(s)
Cell Nucleus/metabolism , Receptors, Calcitriol/metabolism , Repetitive Sequences, Nucleic Acid/genetics , Response Elements/genetics , Electrophoresis , Histone Acetyltransferases , Humans , Ligands , Nuclear Receptor Coactivator 1 , Nuclear Receptor Coactivator 3 , Plasmids/genetics , Receptors, Steroid/genetics , Thyroid Hormones/physiology , Transcription Factors/genetics , Transfection/genetics
17.
Trends Endocrinol Metab ; 11(4): 123-8, 2000.
Article in English | MEDLINE | ID: mdl-10754532

ABSTRACT

Thyroid hormone (TH) plays a crucial role in brain development. Developing rodent cerebellum might be an excellent model for studying the molecular mechanisms of TH action in the brain because perinatal hypothyroidism greatly affects its ontogeny. Although the TH-regulated genes that play crucial roles in cerebellar development have not yet been fully characterized, recent studies have provided novel insights into TH action in brain development.


Subject(s)
Brain/embryology , Brain/growth & development , Thyroid Hormones/physiology , Animals , Animals, Newborn/growth & development , Embryo, Mammalian/physiology , Embryo, Nonmammalian , Embryonic and Fetal Development
18.
J Soc Gynecol Investig ; 6(4): 169-78, 1999.
Article in English | MEDLINE | ID: mdl-10486777

ABSTRACT

GnRH plays a critical role in regulating mammalian reproductive development and function. At the level of the anterior pituitary, GnRH binds to the GnRH receptor (GnRHR) on the cell surface of pituitary gonadotropes. Here, it activates intracellular signal transduction pathways to effect both the synthesis and intermittent release of the gonadotropins LH and FSH. These hormones then enter the systemic circulation to regulate gonadal function, including steroid hormone synthesis and gametogenesis. The response of pituitary gonadotropes to GnRH correlates directly with the concentration of GnRHR on the cell surface, which is mediated, at least in part, at the level of gene expression. A number of endocrine, paracrine, and autocrine factors are known to regulate GnRHR gene expression. This article reviews in detail the role of the GnRHR in the hypothalamic-pituitary-gonadal axis and the factors mediating expression of this gene. A better understanding of the molecular mechanisms that regulate transcription of the GnRHR gene will further our knowledge about the role of this receptor in mammalian reproductive physiology in health and disease.


Subject(s)
Gene Expression Regulation/physiology , Receptors, LHRH/genetics , Receptors, LHRH/physiology , Animals , Female , Hormones/physiology , Humans , Menstrual Cycle/physiology , Mutation , Pituitary Gland/metabolism , Promoter Regions, Genetic/genetics , Regulatory Sequences, Nucleic Acid/genetics , Regulatory Sequences, Nucleic Acid/physiology
19.
Endocrinology ; 140(9): 3955-61, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10465264

ABSTRACT

Thyroid hormone (TH) plays a critical role in normal cerebellar development. However, the molecular mechanisms of TH action in the developing cerebellum are not fully understood. This action could be exerted in part through brain-derived neurotropic factor (BDNF), as cerebellar BDNF messenger RNA (mRNA) expression is lower, and replacement of BDNF partially reverses the abnormal neurogenesis in the hypothyroid rat. The rat BDNF gene consists of four noncoding exons (exons I-IV), each of which is linked to a different promoter, and a protein-coding exon (exon V). To study promoter-specific regulation of the BDNF gene by TH, ribonuclease protection assay of each exon mRNA was performed using total developing rat cerebellar RNA. During cerebellar development, all exon mRNAs were detected, but with different expression patterns; among noncoding exon mRNAs, exon II mRNA was the most abundant. Daily TH replacement induced a 3-fold increase in exon II mRNA on postnatal day (P) 15. On P30, exon II mRNA was still much greater in the TH-replaced animal. Exon I mRNA was detected on P2 and P7. However, in contrast to exon II mRNA, TH treatment suppressed the expression of exon I mRNA on P2. Exon III and IV mRNAs were not detected on P2 and P7, but small amounts were observed starting on P15 in TH-replaced animals. They were not detected by P30 in hypothyroid animals. In contrast, in the cerebral cortex, although all exons are differentially regulated during development, the expression of each mRNA was not significantly altered by TH. These results indicate that TH regulates BDNF gene expression in a promoter-, developmental stage-, and brain region-specific manner, which may play an important role in region- and stage-specific regulation of brain development by TH.


Subject(s)
Aging/physiology , Brain-Derived Neurotrophic Factor/genetics , Cerebellum/physiology , Gene Expression Regulation, Developmental/physiology , Promoter Regions, Genetic/physiology , Thyroxine/physiology , Animals , Animals, Newborn/growth & development , Animals, Newborn/physiology , Brain/metabolism , Cerebellum/growth & development , Exons/physiology , Nucleic Acid Hybridization , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Ribonucleases
20.
J Cell Biochem ; 74(4): 684-93, 1999 Sep 15.
Article in English | MEDLINE | ID: mdl-10440937

ABSTRACT

Thyroid hormones influence both bone formation and bone resorption. Clinical data and animal studies provide evidence of skeletal site heterogeneity (hip vs. spine) of bone responses to thyroid hormones. In vitro studies also demonstrate direct effects of thyroid hormones on cells of the osteoblast lineage. Transcriptional regulation by thyroid hormone is mediated by ligand-dependent transcription factors called thyroid hormone receptors (TRs). Two genes, c-ErbAalpha and c-ErbAbeta, generate at least four TR isoforms in the rat: TRalpha(1), c-erbAalpha(2), TRbeta(1), and TRbeta(2). Although functional TRs have been identified in cells of the osteoblast lineage, it is still not known if TR isoform expression in bone differs depending upon which skeletal site is examined. We have used ribonuclease protection assay and Northern blot analysis to simultaneously examine the expression of TR isoform mRNAs in adult rat femoral and vertebral bone. TRalpha(1), c-erbAalpha(2), and TRbeta(1) are expressed in both femur and vertebra whole bone. Bone marrow cells from both skeletal sites were also cultured under conditions whereby the osteoprogenitors differentiated into osteoblasts and formed a mineralized extracellular matrix. TRalpha(1), c-erbAalpha(2), and TRbeta(1) mRNAs are each expressed in both femoral and vertebral osteoblast cultures. The presence of TRalpha(1), c-erbAalpha(2), and beta(1) proteins was confirmed by Western analysis of nuclear protein extracts from femoral and vertebral cell cultures. These results indicate that the three predominant TR isoforms are highly expressed in bone and osteoblasts from femurs and vertebrae. Whether there are distinct mechanisms of thyroid hormone action mediated by TRalpha(1), c-erbAalpha(2), and TRbeta(1) at these separate skeletal sites remain to be shown.


Subject(s)
Bone Marrow Cells/metabolism , Bone and Bones/metabolism , Osteoblasts/metabolism , Receptors, Thyroid Hormone/metabolism , Animals , Female , Femur/metabolism , Gene Expression , Humans , Protein Isoforms/genetics , Protein Isoforms/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Thyroid Hormone/genetics , Spine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...